These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12830011)

  • 21. A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection.
    Zhu ZZ; Cong WM; Liu SF; Xian ZH; Wu WQ; Wu MC; Gao B; Hou LF; Zhu GS
    Cancer Lett; 2005 Nov; 229(1):77-83. PubMed ID: 15979781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FPIN's clinical inquiries. Screening for hepatocellular carcinoma in patients with hepatitis C virus infection.
    Bossenbroek Fedoriw K; Rickett K
    Am Fam Physician; 2013 Mar; 87(6):online. PubMed ID: 23547582
    [No Abstract]   [Full Text] [Related]  

  • 23. Hepatitis C virus and hepatocellular carcinoma.
    Garrido-Serrano A; León R; Hernández A; Márquez JL
    Rev Esp Enferm Dig; 2011 May; 103(5):281-2. PubMed ID: 21619399
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of limited and anatomic hepatic resection for hepatocellular carcinoma with hepatitis C.
    Kaibori M; Matsui Y; Hijikawa T; Uchida Y; Kwon AH; Kamiyama Y
    Surgery; 2006 Mar; 139(3):385-94. PubMed ID: 16546504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is microRNA-143 really a turncoat of tumor suppressor microRNA in hepatitis B virus-related hepatocellular carcinoma?
    Zhang R; Wang L; Yang AG
    Hepatology; 2009 Sep; 50(3):987; author reply 987-8. PubMed ID: 19670426
    [No Abstract]   [Full Text] [Related]  

  • 26. Cytokines and liver injury in chronic HCV genotype 4 infection.
    Zekry A
    J Gastroenterol Hepatol; 2009 Mar; 24(3):332-5. PubMed ID: 19335783
    [No Abstract]   [Full Text] [Related]  

  • 27. [Oncogenes and suppressor oncogenes in C-type hepatocellular carcinoma].
    Tsukiyama-Kohara K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):619-23. PubMed ID: 15359872
    [No Abstract]   [Full Text] [Related]  

  • 28. DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control.
    Chang PC; Chi CW; Chau GY; Li FY; Tsai YH; Wu JC; Wu Lee YH
    Oncogene; 2006 Mar; 25(14):1991-2003. PubMed ID: 16301996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B 1762T/1764A mutations, hepatitis C infection, and codon 249 p53 mutations in hepatocellular carcinomas from Thailand.
    Kuang SY; Lekawanvijit S; Maneekarn N; Thongsawat S; Brodovicz K; Nelson K; Groopman JD
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):380-4. PubMed ID: 15734961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [miR-122 continues to surprise us].
    Mengardi C; Ohlmann T
    Med Sci (Paris); 2015; 31(6-7):612-5. PubMed ID: 26152164
    [No Abstract]   [Full Text] [Related]  

  • 31. Elevated levels of circulating cell-free DNA in the blood of patients with hepatitis C virus-associated hepatocellular carcinoma.
    Iizuka N; Sakaida I; Moribe T; Fujita N; Miura T; Stark M; Tamatsukuri S; Ishitsuka H; Uchida K; Terai S; Sakamoto K; Tamesa T; Oka M
    Anticancer Res; 2006; 26(6C):4713-9. PubMed ID: 17214331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma.
    Cantarini MC; Trevisani F; Morselli-Labate AM; Rapaccini G; Farinati F; Del Poggio P; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Bernardi M;
    Am J Gastroenterol; 2006 Jan; 101(1):91-8. PubMed ID: 16405539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for hepatocellular carcinoma in high-risk patients: Western versus Eastern virus.
    Huo TI; Lee SD; Wu JC
    Hepatology; 2003 Jul; 38(1):269; author reply 270. PubMed ID: 12830012
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparison of hepatitis B virus and hepatitis C virus seroprevalence in hepatocellular carcinoma].
    Sarr A; Sow AM; Diallo A; Mendez V; Ka Cisse M
    Dakar Med; 1996; Spec No():21-3. PubMed ID: 14520981
    [No Abstract]   [Full Text] [Related]  

  • 35. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
    J Gastroenterol Hepatol; 2008 Mar; 23(3):459-66. PubMed ID: 17854425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations in the E2-PePHD region of hepatitis C virus type 1b in patients with hepatocellular carcinoma.
    Bagaglio S; De Mitri MS; Lodrini S; Paties C; Cassini R; Bianchi G; Bernardi M; Lazzarin A; Morsica G
    J Viral Hepat; 2005 May; 12(3):243-50. PubMed ID: 15850464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C virus genotype 1b, cirrhosis, and risk of hepatocellular carcinoma.
    Sangiovanni A; Iavarone M
    Hepatology; 2008 Jan; 47(1):357; author reply 357-8. PubMed ID: 18161732
    [No Abstract]   [Full Text] [Related]  

  • 38. Trends of aetiological factors of hepatocellular carcinoma in Italy.
    Stroffolini T; Sagnelli E; Mele A; Almasio P
    Dig Liver Dis; 2005 Dec; 37(12):985-6. PubMed ID: 16169300
    [No Abstract]   [Full Text] [Related]  

  • 39. Familial clustering of HCV-related liver cirrhosis and hepatocellular carcinoma.
    Pasta L; Marrone C; D'amico M; Bevacqua EA; D'Amico G; Pagliaro L
    Dig Liver Dis; 2005 Sep; 37(9):716-7. PubMed ID: 15935745
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hepatocellular carcinoma].
    Aihara T; Miyoshi Y; Nakamura Y
    Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1747-53. PubMed ID: 9279108
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.